Purchase this report

Diabetic Macular Edema (Metabolic Disorder) - Drugs in Development, 2021

Published	Pages	Publisher	Report code
Mar 2021	375	Global Markets Direct	ASDR-577287

Published: Mar 2021 - Pages : 375 - Publisher : Global Markets Direct - Report code : ASDR-577287

Diabetic Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Published: March, 2022 - Pages: 260 - US$ 2,500.00
Diabetic Macular Edema - Pipeline Review, H2 2020 Published: July, 2020 - Pages: 319 - US$ 2,000.00
Diabetic Neuropathic Foot Ulcers (Metabolic Disorders) - Drugs in Development, 2021 Published: April, 2021 - Pages: 30 - US$ 2,000.00
Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021 Published: April, 2021 - Pages: 35 - US$ 2,000.00
Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 Published: April, 2021 - Pages: 50 - US$ 2,000.00
Diabetic Nephropathy (Metabolic Disorder) - Drugs In Development, 2021 Published: July, 2021 - Pages: 340 - US$ 2,000.00
Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021 Published: July, 2021 - Pages: 68 - US$ 2,000.00
Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021 Published: October, 2021 - Pages: 218 - US$ 2,000.00
Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 Published: October, 2021 - Pages: 149 - US$ 2,000.00
Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021 Published: October, 2021 - Pages: 424 - US$ 2,000.00

Mark your calendar:

Virtual Seminar on SOP Writing, Training and Compliance in the Pharmaceutical Industry

20 July, 2022
Online Event, Your Computer